Icagen, Inc. - FORM 10-Q - EX-32.1 - CERTIFICATION - February 19, 2020

Attached files

file filename
EX-4.2 - FORBEARANCE AGREEMENT AND FIRST AMENDMENT TO CREDIT AGREEMENT AND GUARANTY ENTER - Icagen, Inc.f10q0919ex4-2_icageninc.htm
EX-32.2 - CERTIFICATION - Icagen, Inc.f10q0919ex32-2_icageninc.htm
EX-31.2 - CERTIFICATION - Icagen, Inc.f10q0919ex31-2_icageninc.htm
EX-31.1 - CERTIFICATION - Icagen, Inc.f10q0919ex31-1_icageninc.htm
EX-10.2 - FORM OF VOTING AND SUPPORT AGREEMENT - Icagen, Inc.f10q0919ex10-2_icageninc.htm
EX-10.1 - ASSET PURCHASE AGREEMENT DATED AS OF FEBRUARY 11, 2020 BY AND BETWEEN ICAGEN, IN - Icagen, Inc.f10q0919ex10-1_icageninc.htm
EX-4.7 - WARRANT TO PURCHASE 599,991 SHARES OF COMMON STOCK ISSUED TO PERCEPTIVE CREDIT H - Icagen, Inc.f10q0919ex4-7_icageninc.htm
EX-4.6 - FORBEARANCE AGREEMENT AND THIRD AMENDMENT TO CREDIT AGREEMENT AND GUARANTY ENTER - Icagen, Inc.f10q0919ex4-6_icageninc.htm
EX-4.5 - FORBEARANCE AGREEMENT AND THIRD AMENDMENT TO CREDIT AGREEMENT AND GUARANTY ENTER - Icagen, Inc.f10q0919ex4-5_icageninc.htm
EX-4.4 - FORBEARANCE AGREEMENT AND SECOND AMENDMENT TO CREDIT AGREEMENT AND GUARANTY ENTE - Icagen, Inc.f10q0919ex4-4_icageninc.htm
EX-4.3 - FORBEARANCE AGREEMENT AND SECOND AMENDMENT TO CREDIT AGREEMENT AND GUARANTY ENTE - Icagen, Inc.f10q0919ex4-3_icageninc.htm
EX-4.1 - FORBEARANCE AGREEMENT AND FIRST AMENDMENT TO CREDIT AGREEMENT AND GUARANTY ENTER - Icagen, Inc.f10q0919ex4-1_icageninc.htm
10-Q - QUARTERLY REPORT - Icagen, Inc.f10q0919_icageninc.htm

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Icagen, Inc. (the “Registrant”) on Form 10-Q for the period ending September 30, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Richard Cunningham, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

Date: February 18, 2020 By: /s/ Richard Cunningham
    Richard Cunningham
   

President and Chief Executive Officer

(Principal Executive Officer)

 

Icagen, Inc. Reports